Conforming with previous studies which mostly used peripheral blood samples, our pleural effusions study also confirmed the elevated levels of CA12, CD40, IL-6, IL-8, PD-L1, and VEGFA, proposing their potential either as biomarkers for severity and prognosis of the disease or targets for therapy. This evidence concerns the gene VEGFA and Pleural effusion.